Health Care & Life Sciences » Pharmaceuticals | Tianjin Zhongxin Pharmaceutical Group Corp. Ltd.

Tianjin Zhongxin Pharmaceutical Group Corp. Ltd. | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
796
631
1,310
1,365
1,093
1,520
Total Accounts Receivable
1,484
1,741
1,596
1,519
1,603
1,792
Inventories
817
860
974
929
1,104
1,328
Other Current Assets
87
151
119
141
161
139
Total Current Assets
3,184
3,383
3,999
3,954
3,961
4,780
Net Property, Plant & Equipment
886
871
924
1,004
1,088
1,200
Total Investments and Advances
887
888
863
1,203
1,279
797
Intangible Assets
199
193
188
181
179
175
Other Assets
21
15
13
11
6
21
Total Assets
5,262
5,438
6,069
6,444
6,622
7,105
ST Debt & Current Portion LT Debt
1,408
1,042
606
532
614
Accounts Payable
554
659
645
546
538
Income Tax Payable
13
9
12
19
29
Other Current Liabilities
633
652
577
872
680
Total Current Liabilities
2,608
2,363
1,840
1,969
1,861
Long-Term Debt
4
-
-
-
-
Provision for Risks & Charges
-
54
48
47
40
Deferred Taxes
80
80
73
84
103
Other Liabilities
-
4
4
4
4
Total Liabilities
2,616
2,429
1,901
2,027
1,912
Common Equity (Total)
2,417
2,764
3,922
4,183
4,477
Total Shareholders' Equity
2,417
2,764
3,922
4,183
4,477
Total Equity
2,575
2,947
4,105
4,345
4,625
Liabilities & Shareholders' Equity
5,262
5,438
6,069
6,444
6,622
Accumulated Minority Interest
158
183
183
163
149
Non-Equity Reserves
71
62
62
71
84

About Tianjin Zhongxin Pharmaceutical Group Corp.

View Profile
Address
Zhongxin Building
Tianjin Tianjin 300193
China
Employees -
Website -
Updated 07/08/2019
Tianjin Zhong Xin Pharmaceutical Group Corp. Ltd. engages in the manufacture and sale of traditional Chinese medicine. Its business covers proprietary Chinese medicines, Chinese herbal medicines, chemical raw materials and preparations, biomedicine, nutritional supplements research and development and manufacturing, and commercial medicine. Its products include cardiovascular medicine, respiratory medicine, spleen and stomach medicine, cold medicine, cancer medication, gynecology, pediatrics and other multi-product groups.